These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35328625)

  • 1. Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids.
    Lee S; Mendoza TR; Burner DN; Muldong MT; Wu CCN; Arreola-Villanueva C; Zuniga A; Greenburg O; Zhu WY; Murtadha J; Koutouan E; Pineda N; Pham H; Kang SG; Kim HT; Pineda G; Lennon KM; Cacalano NA; Jamieson CHM; Kane CJ; Kulidjian AA; Gaasterland T; Jamieson CAM
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.
    Li F; Han M; Dai P; Xu W; He J; Tao X; Wu Y; Tong X; Xia X; Guo W; Zhou Y; Li Y; Zhu Y; Zhang X; Liu Z; Aji R; Cai X; Li Y; Qu D; Chen Y; Jiang S; Wang Q; Ji H; Xie Y; Sun Y; Lu L; Gao D
    Nat Commun; 2021 Feb; 12(1):866. PubMed ID: 33558541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
    Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE
    Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells.
    Leach DA; Mohr A; Giotis ES; Cil E; Isac AM; Yates LL; Barclay WS; Zwacka RM; Bevan CL; Brooke GN
    Nat Commun; 2021 Jul; 12(1):4068. PubMed ID: 34210968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids.
    Ahmad Mulyadi Lai HI; Chou SJ; Chien Y; Tsai PH; Chien CS; Hsu CC; Jheng YC; Wang ML; Chiou SH; Chou YB; Hwang DK; Lin TC; Chen SJ; Yang YP
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway.
    Sekhar KR; Wang J; Freeman ML; Kirschner AN
    PLoS One; 2019; 14(4):e0214670. PubMed ID: 30933998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.
    Dondoo TO; Fukumori T; Daizumoto K; Fukawa T; Kohzuki M; Kowada M; Kusuhara Y; Mori H; Nakatsuji H; Takahashi M; Kanayama HO
    Anticancer Res; 2017 Jan; 37(1):125-134. PubMed ID: 28011482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of enzalutamide-resistant cell model of prostate cancer and preliminary screening of potential drug-resistant genes.
    Feng T; Wei D; Zhao J; Li Q; Guo P; Yang X; Li M; Jiang Y; Luo Y
    Exp Biol Med (Maywood); 2021 Aug; 246(15):1776-1787. PubMed ID: 34034559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway.
    Afshari A; Janfeshan S; Yaghobi R; Roozbeh J; Azarpira N
    Infect Genet Evol; 2021 Mar; 88():104669. PubMed ID: 33301988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer.
    Efstathiou E; Titus M; Wen S; Hoang A; Karlou M; Ashe R; Tu SM; Aparicio A; Troncoso P; Mohler J; Logothetis CJ
    Eur Urol; 2015 Jan; 67(1):53-60. PubMed ID: 24882673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes.
    Baratchian M; McManus JM; Berk MP; Nakamura F; Mukhopadhyay S; Xu W; Erzurum S; Drazba J; Peterson J; Klein EA; Gaston B; Sharifi N
    Sci Rep; 2021 May; 11(1):11130. PubMed ID: 34045511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer.
    Armstrong CM; Liu C; Liu L; Yang JC; Lou W; Zhao R; Ning S; Lombard AP; Zhao J; D'Abronzo LS; Evans CP; Li PK; Gao AC
    Clin Cancer Res; 2020 Nov; 26(22):6064-6074. PubMed ID: 32928794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
    Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
    J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9
    Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C
    Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer.
    Chou FJ; Lin C; Tian H; Lin W; You B; Lu J; Sahasrabudhe D; Huang CP; Yang V; Yeh S; Niu Y; Chang C
    Cell Death Dis; 2020 Nov; 11(11):942. PubMed ID: 33139720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.
    Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikström P
    Eur Urol; 2017 May; 71(5):776-787. PubMed ID: 27497761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models.
    Weyer-Czernilofsky U; Hofmann MH; Friedbichler K; Baumgartinger R; Adam PJ; Solca F; Kraut N; Nguyen HM; Corey E; Liu G; Sprenger CC; Plymate SR; Bogenrieder T
    Mol Cancer Ther; 2020 Apr; 19(4):1059-1069. PubMed ID: 32054790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancer.
    Porter LH; Bakshi A; Pook D; Clark A; Clouston D; Kourambas J; ; Goode DL; Risbridger GP; Taylor RA; Lawrence MG
    J Pathol; 2021 Jun; 254(2):121-134. PubMed ID: 33620092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.
    Zhou L; Zhang C; Yang X; Liu L; Hu J; Hou Y; Tao H; Sugimura H; Chen Z; Wang L; Chen K
    Clin Transl Med; 2021 Jun; 11(6):e449. PubMed ID: 34185414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.
    Lin TH; Lee SO; Niu Y; Xu D; Liang L; Li L; Yeh SD; Fujimoto N; Yeh S; Chang C
    J Biol Chem; 2013 Jul; 288(27):19359-69. PubMed ID: 23687298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.